Claims
- 1. A compound of formula (la) or (Ib) ##STR8## wherein R.sup.1 and R.sup.2 are each independently selected from the group consisting of hydrogen, straight-chained or branched C.sub.1 -C.sub.6 alkyl, cycloalkyl and aryl, or R.sup.1 and R.sup.2 together form a cycloalkyl or aryl,
- with the proviso that at most one of R.sup.1 and R.sup.2 is hydrogen;
- R.sup.3 is a group which is capable of being cleaved off the O atom to which it is attached by an activating agent;
- R.sup.4 and R.sup.5 are each independently hydrogen or a stabilizing group which protects the dioxetane group from uncontrolled conversion, or R.sup.4 and R.sup.5 together form a stabilizing group,
- with the proviso that at most one of R.sup.4 and R.sup.5 is hydrogen;
- W is selected from the group consisting of hydrogen, halogen and pseudohalogen;
- X and Y are each independently selected from the group consisting of a double bond, a carbonyl group, oxygen, N-R and C(R).sub.2, wherein R has the meanings of R.sup.1 and R.sup.2 above,
- m is 1 or 2; and
- n is 0 or 1.
- 2. The compound of claim 1, wherein the compound is selected from the group consisting of:
- a compound of formula (la), wherein X is oxygen, n is 0 and O-R.sup.3 is located on position 5 of the phenyl ring;
- a compound of formula (Ib), wherein m is 1 and O-R.sup.3 is located on position 3 of the phenyl ring; and
- a compound of formula (Ib), wherein m is 2 and O-R.sup.3 is located on position 4 of the phenyl ring,
- wherein R.sup.1 -R.sup.5, W and Y are as defined above.
- 3. The compound of claim 1, wherein O-R.sup.3 is selected from the group consisting of a hydroxy salt, an oxy acid, a phosphate group, an arylcarboxylic ester, an alkylcarboxylic ester, an alkyloxy group, a trialkyloxy group, an alkylsilyloxy group, an arylsilyloxy group, a sulfate group, an oxypyranoside, a glyceridyl group and a phosphoryl group.
- 4. The compound of claim 1, wherein O-R.sup.3 is a phosphate group or a dimethyl-tertiary butyl-silyloxy group.
- 5. The compound of claim 1, wherein R.sup.1 and R.sup.2 are each independently selected from the group consisting of hydrogen, methyl, ethyl and phenyl which is unsubstituted or substituted, or R.sup.1 and R.sup.2, together with the carbon atoms to which they are bound, form a phenylene group which is unsubstituted or substituted.
- 6. The compound of claim 1, wherein R.sup.4 and R.sup.5, together with the carbon atoms to which they are bound, form a condensed aliphatic or aromatic ring system which is unsubstituted or has at least one electron withdrawing group as a substitutent.
- 7. The compound of claim 6, wherein R.sup.4 and R.sup.5 are selected from the group consisting of adamantanyl group, phenyl group, cyclohexyl group, secondary or tertiary aliphatic alkyl group, polycycloalkyl group, polycycloaryl group, or a steroid derivative group, wherein any of the groups are unsubstituted or substituted with at least one electron withdrawing group.
- 8. The compound of claim 1, wherein the compound is of formula (la') or (la") ##STR9## wherein R.sup.1 -R.sup.3 and W are as defined above.
- 9. The compound of claim 8, wherein the compound is selected from the group consisting of:
- 3-(7'-t.-butyldimethylsilyloxy-2',2'-dimethyl-benzofuran-3'-yl)-4-spiro-(tricyclor3.3.1.1..sup.3,7 ]yl)-1,2-dioxetane, a disodium salt of 3-(7'-phosphoryl-2',2'-dimethyl-benzofuran-3'-yl)-4-spiro-(tricyclo [3.3.1.1..sup.3,7 ]yl)-1,2-dioxetane, 3-(7'-t.-butyl-dimethylsilyloxy-2',2'-dimethyl-benzofuran-3'-yl)-4-spiro-(5"-chloro-tricyclo [3.3.1.1..sup.3,7 ]yl)-1,2-dioxetane, a disodium salt of 3-(7'-phosphoryl-2',2'-dimethyl-benzofuran-3'-yl)-4-spiro-(5"-chloro-tricyclo [3.3.1.1..sup.3,7 ]-yl)-1,2-dioxetane, 3-(5'-t.-butyldimethylsilyloxy-2',2'-dimethyl-benzofuran-3'-yl)-4-spiro-(5"-chloro-tricyclo [3.3.1.1..sup.3,7 ]yl)-1,2-dioxetane, a disodium salt of 3-(5'-phosphoryl-2',2'-dimethyl-benzofuran-3'-yl)-4-spiro-(5"-chloro-tricyclo [3.3.1.1..sup.3,7 ]yl)-1,2-dioxetane, 3-(5'-t.-butyldimethylsilyloxy-6'-chloro-2',2'-dimethyl-benzofuran-3'-yl)-4-spiro-(5"-chloro-tricyclo [3.3.1.1..sup.3,7 ]yl)-1,2-dioxetane, a disodium salt of 3-(5'-phosphoryl-6'-chloro-2',2'-dimethyl-benzofuran-3'-yl)-4-spiro-(5"-chloro-tricyclo [3.3.1.1..sup.3,7 ]yl)-1,2-dioxetane, (4.XI.-)-5"-t.-butyldimethylsilyloxy-6"-chloro-2",2"-dimethyl-17-oxo-(3.zeta.)-dispiro[androsta-1,4-diene-3,3'-[1,2]dioxetane-4',3"-benzofurane and(4.XI.)-6"-chloro-2",2"-dimethyl-17-oxo-(3.xi.)-dispiro[androsta-1,4-diene-3,3'-[1,2]dioxetane-4',3"-benzofuran-5"-yl-disodium phosphate.
- 10. A method for determining an analyte, comprising reacting the analyte with a compound as claimed in claim 1 to cleave the group R.sup.3 therefrom to produce light from the reaction, and thereafter measuring the produced light to determined the analyte.
- 11. The method of claim 10, wherein the analyte is selected from the group consisting of an acid, a base, a salt, an enzyme, a DNA, an inorganic or organic catalyst and an electron donor.
- 12. The method of claim 10, wherein the analyte is an enzyme or a DNA.
- 13. The compound of claim 6 wherein at least one electron withdrawing group is a group with a positive .delta..sub.p value.
Priority Claims (1)
Number |
Date |
Country |
Kind |
195 38 708 |
Oct 1995 |
DEX |
|
Parent Case Info
This application is a 371 of PCT/EP96/04506 Oct. 17, 1996.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/EP96/04506 |
10/17/1996 |
|
|
4/20/1998 |
4/20/1998 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO97/14696 |
4/24/1997 |
|
|
US Referenced Citations (3)
Number |
Name |
Date |
Kind |
5770743 |
Schaap et al. |
Jun 1998 |
|
5773628 |
Akhavan-Tafti et al. |
Jun 1998 |
|
5929254 |
Matsumoto et al. |
Jul 1999 |
|